Publications - Abbkine – Antibodies, proteins, biochemicals, assay kits for life science research

Catalog no	Product name	Protocol name	IF	Magazine title
A23310	Dylight 549, Goat Anti-Mouse IgG	A novel PDE4 inhibitor ZX21011 alleviates neuronal apoptosis by decreasing GSK3β-mediated Drp1 Ser616 phosphorylation in cerebral ischemia reperfusion.(A23310-5.4)	5.4	Chemico-Biological Interactions
BMU102		A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growth.(BMU102-52.7)	52.7	Signal Transduction and Targeted Therapy
A02010AGB		A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin(A02010AGB-)		Journal of Biological Chemistry
KTB1910	CheKine™ Reactive Oxygen Species (ROS) Detection Fluorometric Assay Kit	A novel peptide TCL6148 induces ferroptosis via the GOT1/GPX4 pathway to enhance sunitinib sensitivity in renal cell carcinoma.(KTB1910-8.5)	8.5	International Journal of Biological Macromolecules
KTD3010		A novel peptide TCL6148 induces ferroptosis via the GOT1/GPX4 pathway to enhance sunitinib sensitivity in renal cell carcinoma.(KTD3010-8.5)	8.5	International Journal of Biological Macromolecules
A23420	Dylight 594, Goat Anti-Rabbit IgG	A novel polypeptide encoded by circSPIRE1 promotes prostate cancer proliferation and migration by restraining the ubiquitin-dependent degradation of LRP5(A23420-12.8)	12.8	signal transduction and targeted therapy
KTB1110	CheKine™ Micro Lactate Dehydrogenase (LDH) Assay Kit	A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma(KTB1110-3.4)	3.4	Cells
KTA1020	Cell Counting Kit-8 (CCK-8)	A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma.(KTA1020-3.4)	3.4	Journal of Hepatocellular Carcinoma
KTB1016	CheKine™ Micro ATP Content Assay Kit	A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma.(KTB1016-3.4)	3.4	Journal of Hepatocellular Carcinoma
KTB1100	CheKine™ Micro Lactate Assay Kit	A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma.(KTB1100-3.4)	3.4	Journal of Hepatocellular Carcinoma

First Pre 10 11 12 13 14 15 16 17 18 19 20 Next Last

Welcome any form of communications, and better service will be provided here.

Tell： +1-404-854-0155

Support Email： support@abbkine.com

Address： 3052 Stroop Hill Road, Apt 203, Atlanta 30303, Georgia, United States of America

Cart

Technical

Recent articles

RECEIVE OFFERS BY EMAIL

CONTACT US

Links：